These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34135892)

  • 1. Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses.
    Chuang GY; Shen CH; Cheung CS; Gorman J; Creanga A; Joyce MG; Leung K; Rawi R; Wang L; Yang ES; Yang Y; Zhang B; Zhang Y; Kanekiyo M; Zhou T; DeKosky BJ; Graham BS; Mascola JR; Kwong PD
    Front Immunol; 2021; 12():662909. PubMed ID: 34135892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of a classical broadly neutralizing stem antibody in complex with a pandemic H2 influenza virus hemagglutinin.
    Dreyfus C; Ekiert DC; Wilson IA
    J Virol; 2013 Jun; 87(12):7149-54. PubMed ID: 23552413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.
    Iba Y; Fujii Y; Ohshima N; Sumida T; Kubota-Koketsu R; Ikeda M; Wakiyama M; Shirouzu M; Okada J; Okuno Y; Kurosawa Y; Yokoyama S
    J Virol; 2014 Jul; 88(13):7130-44. PubMed ID: 24719430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.
    Williams JA; Gui L; Hom N; Mileant A; Lee KK
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in V
    Lang S; Xie J; Zhu X; Wu NC; Lerner RA; Wilson IA
    Cell Rep; 2017 Sep; 20(12):2935-2943. PubMed ID: 28930686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses.
    Joyce MG; Wheatley AK; Thomas PV; Chuang GY; Soto C; Bailer RT; Druz A; Georgiev IS; Gillespie RA; Kanekiyo M; Kong WP; Leung K; Narpala SN; Prabhakaran MS; Yang ES; Zhang B; Zhang Y; Asokan M; Boyington JC; Bylund T; Darko S; Lees CR; Ransier A; Shen CH; Wang L; Whittle JR; Wu X; Yassine HM; Santos C; Matsuoka Y; Tsybovsky Y; Baxa U; ; Mullikin JC; Subbarao K; Douek DC; Graham BS; Koup RA; Ledgerwood JE; Roederer M; Shapiro L; Kwong PD; Mascola JR; McDermott AB
    Cell; 2016 Jul; 166(3):609-623. PubMed ID: 27453470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-idiotype isolation of a broad and potent influenza A virus-neutralizing human antibody.
    Olia AS; Prabhakaran M; Harris DR; Cheung CS; Gillespie RA; Gorman J; Hoover A; Morano NC; Ourahmane A; Srikanth A; Wang S; Wu W; Zhou T; Andrews SF; Kanekiyo M; Shapiro L; McDermott AB; Kwong PD
    Front Immunol; 2024; 15():1399960. PubMed ID: 38873606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovering neutralizing antibodies targeting the stem epitope of H1N1 influenza hemagglutinin with synthetic phage-displayed antibody libraries.
    Tung CP; Chen IC; Yu CM; Peng HP; Jian JW; Ma SH; Lee YC; Jan JT; Yang AS
    Sci Rep; 2015 Oct; 5():15053. PubMed ID: 26456860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
    Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A highly conserved neutralizing epitope on group 2 influenza A viruses.
    Ekiert DC; Friesen RH; Bhabha G; Kwaks T; Jongeneelen M; Yu W; Ophorst C; Cox F; Korse HJ; Brandenburg B; Vogels R; Brakenhoff JP; Kompier R; Koldijk MH; Cornelissen LA; Poon LL; Peiris M; Koudstaal W; Wilson IA; Goudsmit J
    Science; 2011 Aug; 333(6044):843-50. PubMed ID: 21737702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broadly neutralizing antibodies against influenza viruses.
    Laursen NS; Wilson IA
    Antiviral Res; 2013 Jun; 98(3):476-83. PubMed ID: 23583287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique structural solution from a V
    Harshbarger WD; Deming D; Lockbaum GJ; Attatippaholkun N; Kamkaew M; Hou S; Somasundaran M; Wang JP; Finberg RW; Zhu QK; Schiffer CA; Marasco WA
    Nat Commun; 2021 Jan; 12(1):559. PubMed ID: 33495478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Monoclonal Antibody Derived from Transchromosomic Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational Epitope in the Hemagglutinin Head Domain.
    Gao R; Sreenivasan CC; Sheng Z; Hause BM; Zhou B; Wentworth DE; Clement T; Rausch D; Brunick C; Christopher-Hennings J; Wu H; Bausch CL; Sullivan EJ; Hoppe AD; Huber VC; Wang D; Li F
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.
    Hufton SE; Risley P; Ball CR; Major D; Engelhardt OG; Poole S
    PLoS One; 2014; 9(8):e103294. PubMed ID: 25084445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccination strategies targeting the hemagglutinin stem region.
    Fukuyama H; Shinnakasu R; Kurosaki T
    Immunol Rev; 2020 Jul; 296(1):132-141. PubMed ID: 32542739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterosubtypic antibodies to influenza A virus have limited activity against cell-bound virus but are not impaired by strain-specific serum antibodies.
    Wyrzucki A; Bianchi M; Kohler I; Steck M; Hangartner L
    J Virol; 2015 Mar; 89(6):3136-44. PubMed ID: 25552718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient.
    Hu W; Chen A; Miao Y; Xia S; Ling Z; Xu K; Wang T; Xu Y; Cui J; Wu H; Hu G; Tian L; Wang L; Shu Y; Ma X; Xu B; Zhang J; Lin X; Bian C; Sun B
    Virology; 2013 Jan; 435(2):320-8. PubMed ID: 23084424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Anti-Influenza Virus Antibody Inhibits Viral Infection by Reducing Nucleus Entry of Influenza Nucleoprotein.
    Yoon A; Yi KS; Chang SY; Kim SH; Song M; Choi JA; Bourgeois M; Hossain MJ; Chen LM; Donis RO; Kim H; Lee Y; Hwang DB; Min JY; Chang SJ; Chung J
    PLoS One; 2015; 10(10):e0141312. PubMed ID: 26512723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.